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Background: C-reactive protein (CRP) has been suggested as an independent risk factor for cardiovascular pathology in the
nonsurgical setting. While postoperative CRP and erythrocyte sedimentation rate (ESR) have an established role in aiding the
diagnosis of periprosthetic joint infections, some authors suggest a link between preoperative CRP and postoperative
complications in patients undergoing total joint arthroplasty.
Methods: We conducted a retrospective cohort study of 351 patients who underwent unilateral primary total knee arthroplasty
by a single surgeon during a 28-month period (January 2013 through April 2015). Patient medical records were reviewed for the
following complications occurring within 90 days postoperatively: myocardial infarction, arrhythmia, pulmonary embolism,
wound infection, acute renal failure, and reoperation.
Results: We found no statistically significant link between postoperative complications and preoperative CRP levels (P¼0.5005)
or ESR levels (P¼0.1610).
Conclusion: The results of this study do not support the routine inclusion of CRP and ESR analysis as part of the preoperative
evaluation for elective total knee arthroplasty.
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INTRODUCTION
After conservative options have failed, total knee arthro-
plasty is an effective treatment for an osteoarthritic and
painful joint. Total knee arthroplasty has become a common
procedure associated with low to moderate risk, but
complications still occur postoperatively, some of which
may be life-threatening or require reoperation. Early
possible complications associated with total knee arthro-
plasty include infection, deep vein thrombosis (DVT),
pulmonary embolism (PE), neurovascular injury, peripros-
thetic fracture, pain, and stiffness.1 Risk factors that have
been identified to increase complications in joint arthroplas-
ty include age >65 years, obesity, comorbidities (eg,
diabetes and hypertension), and surgery performed in a
low-volume hospital.1 Postoperatively, studies have proven
the benefit of using C-reactive protein (CRP) and erythrocyte
sedimentation rate (ESR) in the diagnosis of periprosthetic
joint infections.2,3
CRP and ESR are serum markers that show high
sensitivity for inflammation in the body. ESR measures the
rate at which red blood cells sediment during 1 hour,
serving as a measure of acute phase response. Elevations
in ESR can be the result of inflammation, infection,
neoplasms, tissue ischemia/injury, or trauma. CRP, a
protein produced by the liver and adipose tissues, is a
sensitive and specific marker for inflammation and increases
in direct relation to the degree of inflammation.4 In a
retrospective study of patients who underwent arthroscopic
anterior cruciate ligament reconstruction, CRP and ESR
levels were measured at various times in both the infection
and noninfection groups.5 The study determined that CRP
peaked earlier than ESR in the infection group, and CRP
was more useful than ESR in evaluating the response to
treatment of infection.
In the nonoperative setting, elevated CRP values have
been shown to be associated with increased cardiovascular
risk.6-8 Some authors believe CRP can be used as a
prognostic factor for cardiovascular disease, in addition to
the traditional risk factors.8,9 CRP correlates inversely with
cardiovascular fitness, an important determinant for out-
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comes.9 In a metaanalysis published in 2004, Danesh et al
found that patients were 1.45 times more likely to have
coronary disease when they were in the top third of baseline
CRP compared to the bottom third (odds ratio¼1.45, 95%
confidence ratio 1.25, 1.68).7 Studies since then have
shown similar results.6 Prospective studies suggest CRP
may independently predict a patient’s risk for cardiac death,
stroke, and peripheral arterial disease.8 These links suggest
that CRP may be used when considering global vascular
risk.6
Because elevated CRP appears to be associated with
increased cardiovascular risks in the nonoperative setting, it
seems plausible that an elevated CRP could also be
associated with the risk of postoperative complications.
The aim of this study was to explore if elevated preoperative
levels of CRP and ESR correlated with postoperative
complications among patients receiving primary total knee
arthroplasty.
METHODS
Orthopedic surgeons frequently order a complete blood
count (CBC) preoperatively to establish baseline hemoglo-
bin and hematocrit levels. In addition to the CBC, one
surgeon (J.L.O.) at our institution has been collecting CRP
and ESR values as part of his routine preoperative
evaluation for several years. This retrospective cohort study
involved the review of medical records of patients who
received primary total knee replacements during a 28-
month period (January 2013 to April 2015) by a single
surgeon (J.L.O.). The goal of this study was to evaluate if
preoperative inflammatory markers (CRP and ESR) predis-
posed patients to postoperative complications.
Approval was obtained from the Ochsner Institutional
Review Board. All data were obtained from the electronic
medical records. The electronic medical database was
queried for the Current Procedural Terminology (CPT)
code 27447 (primary total knee replacement). The records
of patients who received total knee replacements were
then queried for International Classification of Diseases,
9th Revision (ICD-9) codes for the following complications:
wound infection, acute renal failure, myocardial infarction,
arrhythmia, pulmonary embolism, and reoperation. Early
prosthetic joint infections are defined within the first 3
months after surgery;10 therefore, the time range for
postoperative complications for this study was chosen as
90 days postoperatively. Chart abstraction for all patients
was performed to verify complications and primary surgery
status. Laboratory values of ESR and CRP within 30 days
before the surgery were recorded. All imaging, laboratory
work, electrocardiograms (ECGs), postoperative notes,
and clinic notes were reviewed from the date of surgery
to 90 days postoperatively. All ECGs are reviewed and
read by cardiologists at the time of their request,
increasing the likelihood of correctly identifying cardiac
complications. The following comorbidities were also
recorded during the electronic chart review: diabetes,
Crohn disease, hepatitis C, rheumatoid arthritis, and
urinary tract infections (UTIs). Although UTIs are an acute
infection and not a chronic comorbidity, UTIs may elevate
inflammatory markers and were therefore classified as a
comorbidity.
Inclusion criteria for this study included primary unilateral
total knee replacement. Patients who received surgery for
one knee replacement and then received a subsequent
surgery for the contralateral side (staged bilateral surgeries)
within the time frame (January 2013 to April 2015) were
counted as 2 patients in the analysis. Patients who received
a revision total knee replacement or simultaneous bilateral
total knee replacement, had prior knee hardware, or had
incomplete laboratory values preoperatively were excluded
from this study.
Patients were divided into 3 groups for both CRP and
ESR: low normal, intermediate normal, and high. The
normal range for CRP at our institution is 0-8.2 mg/L, so
the categorization was 0-4.1 mg/L for low normal, 4.2-8.2
mg/L for intermediate normal, and ‡8.3 mg/L for high. The
normal range for ESR is 0-20 mm/h, so the categorization
was 0-10 mm/h for low normal, 11-20 mm/h for intermediate
normal, and ‡21 mm/h for high. These cutoff values were
selected to divide the population across consistent increas-
es in laboratory values. The analysis was a comparison of
the 3 groups for CRP and ESR rather than a comparison of
complications within each group.
Statistical analysis was performed using SAS v.9.4 (SAS
Institute). All data were categorical. The likelihood ratio test
was performed for sample sizes >5. Fisher exact test was
used when groups contained 5 subjects or less. Alpha was
set at 0.05, and any P value less than alpha was considered
to be statistically significant. No statistical tests were
performed for combinations that had too small a sample
size to calculate. CRP and ESR were evaluated indepen-
dently against each complication.
RESULTS
A total of 351 total knee arthroplasties were performed on
317 patients. Thirty-four patients received bilateral surgeries
on different dates more than 90 days apart. As previously
stated, each staged bilateral surgery is considered to be 2
patients. Therefore, the total cohort size is 351 patients.
Total knee replacement was performed on 147 males
(41.88%) and 204 females (58.12%). The patients’ mean
age at time of surgery was 68.87 years (SD 9.57; range, 40-
91 years). Of the 351 total knee replacements, 193 (54.99%)
were performed on the left knee, and 158 were performed
on the right (45.01%).
One hundred twenty-three patients had at least 1
preoperative comorbidity (Table 1). The comorbidity with
the highest incidence was diabetes, reported for 98 patients.
Table 1. Preoperative Comorbidities (n¼351)
Patient Group Number of Patients
Any comorbidity (1 or more) 123 (35.04%)
Diabetes 98 (79.67%)
Rheumatoid arthritis 20 (16.26%)
Urinary tract infection 19 (15.45%)
Crohn disease 3 (2.44%)
Hepatitis C 2 (1.63%)
No comorbidities 228 (64.96%)
Note: Some patients had multiple comorbidities.
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Twenty-eight patients had 1 or more complications (Table
2): 1 patient had myocardial infarction, 8 had new
arrhythmia, 5 had PE or DVT, 12 had acute renal failure,
and 8 had infections. Six of the 8 infections were suspected
to be superficial and described as ‘‘cellulitis.’’ Of the 6
patients with superficial infections, 4 were readmitted and
treated with intravenous (IV) antibiotics, 1 received oral
antibiotics at a skilled nursing facility, and 1 received
outpatient IV and oral antibiotics. The other 2 infections
were deep and required incision and drainage and tibial
polyethylene insert exchange. Additionally, 2 patients
received incision and drainage for persistent drainage with
negative intraoperative cultures. Operative findings revealed
1 case of subcutaneous dehiscence without fascial defect
and 1 case of small superficial hematoma. No patients in
this study required formal revision surgery within 90 days of
the total knee arthroplasty.
When CRP levels were stratified, 173 patients had low-
normal values, 91 patients had intermediate-normal levels,
and 87 patients had high CRP levels. For ESR, 113 patients
had low-normal levels, 75 had intermediate-normal values,
and 163 had high ESR levels. No statistical significance was
found between CRP or ESR and any complication, with P
values of 0.5005 and 0.1610, respectively (Table 3). Any
comorbidity was not a significant predictor for any compli-
cation (P¼0.6347). Any comorbidity was significantly asso-
ciated with elevated CRP and ESR, with P values of 0.0239
and 0.0002, respectively.
DISCUSSION
Although there is currently no consensus on the use of
CRP and ESR for preoperative evaluation of orthopedic
patients, 3 studies exploring this possibility have recently
been published. All 3 studies suggest a link between
preoperative CRP and postoperative complications. A
limitation of all 3 studies is the relatively small sample sizes.
A 2008 study by Pfitzner et al retrospectively evaluated 50
patients in Germany who received primary total hip and knee
arthroplasties.2 The study compared 25 patients with
postoperative infections against a control group of 25
patients without infectious complications matched for de-
mographic data. The infected group had a higher, although
not statistically significant, average preoperative CRP (13 –
25 mg/L) compared to the control group (4 – 7 mg/L). The
authors recommended using a CRP threshold of 5 mg/L to
determine if a cause for infection should be explored.
The other 2 studies evaluated high-sensitivity CRP
(hsCRP) using cutoff values based on the Centers for
Disease Control CRP stratification, classifying patients into
low (<3 mg/L) and high (>3 mg/L) groups. In 2007, Ackland
et al reported that hsCRP correlated to length of stay and
delayed postoperative complications in a cohort of 129
prospectively followed patients who underwent total hip or
knee arthroplasty.9 Laboratory workups were performed at
a mean of 13 days preoperatively (SD 8 days). Ackland et al
found a statistically significant difference in length of stay
and incidence of complications at postoperative day (POD)
8 between high CRP and low CRP groups, but they found
no significant difference in complications on POD 5. In a
prospective, cross-sectional study performed in India and
published in 2009, Ghosh et al studied 121 patients who
received total hip arthroplasty, total knee arthroplasty, andT
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hemiarthroplasty.11 They collected preoperative, periopera-
tive, and postoperative CRP values and found a statistically
significant increase in both operative time and complica-
tions at POD 14; however, the authors found no significant
difference in complications between the groups at POD 7.
In our study, CRP and ESR were not found to be
significantly related to complications. Only 9 of the 87
patients with elevated CRP had any complications, and the
largest groups only included 3 patients (acute renal failure
and arrhythmia). With such small sample sizes, subgroup
analysis would not have enough power to produce
meaningful results.
A potential limitation of our study is that it was
underpowered to show a statistically significant difference.
Also, the comorbidities reported for some of the patients
can independently affect levels of the inflammatory markers,
potentially confounding the findings. Additionally, the
retrospective nature of the study may have led to missing
or omitted information. Attempts to minimize missed
information included selecting complications that would
likely be documented based on severity, using electronic
medical records, and using both ICD-9 code queries and a
review of the clinical notes.
CONCLUSION
This study did not show a statistically significant correla-
tion between postoperative complications and preoperative
ESR or CRP. The small number of patients with complica-
tions may not have been enough to power a statistically
significant study. Further investigation is necessary to
determine if preoperative CRP and ESR relate to postoper-
ative complications among patients undergoing total knee
arthroplasty.
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